Position in ARVN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,442,291
+$293,194 QoQ
Shares Held
654,909
+34.8% QoQ
Ownership
1.00%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 201 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 83%
Shared 8%
None 9%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. ARVN ranks #105 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ARVN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,442,291 | 654,909 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $5,149,097 | 485,764 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $5,602,900 | 472,420 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,672,206 | 665,752 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,917,347 | 668,118 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,223,742 | 744,123 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $16,168,551 | 843,430 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $16,186,243 | 657,176 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $12,349,948 | 463,935 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $17,927,902 | 434,300 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $20,245,655 | 491,877 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $9,218,974 | 469,398 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $5,279,435 | 212,709 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,790,206 | 175,337 | Shares | Sole | 2023-05-12 | |
| 2022-03-31 | $726,840 | 10,800 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,629,875 | 68,540 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $11,113,201 | 135,230 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $7,569,331 | 98,303 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $3,644,886 | 55,142 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,806,528 | 56,594 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $1,519,020 | 64,338 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,993,651 | 59,441 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||